This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Prognosis in HIV

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

 

  • various studies have reported the dramatic decreases in mortality among individuals infected with human immunodeficiency virus (HIV) since the widespread introduction of highly active antiretroviral therapy (HAART) in industrialized countries
    • industrialized countries, persons infected sexually with HIV now appear to experience mortality rates similar to those of the general population in the first 5 years following infection, though a mortality excess remains as duration of HIV infection lengthens
    • individuals exposed to HIV through intravenous drug use had a higher excess risk of death than persons infected sexually with HIV

A review has suggested (2) that people living with HIV can currently expect to live a normal life span if able to achieve durable viral suppression on combination antiretroviral therapy

  • however this requires lifelong medication and will still suffer from higher rates of cardiovascular, renal, liver and neurologic disease

Reference:

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page